EVH insider buying and SEC filings, explained
Evolent Health, Inc. · CIK 1628908
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$38K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$329K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 26, 2026 | Planned (10b5-1) | Daniel Joseph McCarthy (President / COO) sold 65,892 shares at $5.00 ($329K), marked as a 10b5-1 plan trade. Holdings down 9% to 655,133 shares. | SEC filing Filed Aug 28, 2026 |
| Nov 18, 2025 | Purchase (code P) | Brendan B Springstubb (Director) bought 10,000 shares at $3.82 ($38K), reported as a purchase (code P). Holdings up 20% to 58,821 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 19, 2025 |
20 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow EVH in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.